Deutsche Bank
OGEN icon

Deutsche Bank’s Oragenics OGEN Stock Holding History

Deutsche Bank’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20
Closed -$18K – 4673
2019
Q4 		$18K Buy
+20
New +$17.8K ﹤0.01% 4332
2019
Q3 		– Sell
-11
Closed -$9K – 5159
2019
Q2 		$9K Buy
+11
New +$10.1K ﹤0.01% 5000
2018
Q3 		– Sell
-1
Closed -$2K – 5490
2018
Q2 		$2K Buy
+1
New +$2.63K ﹤0.01% 5314
2018
Q1 		– Sell
-1
Closed -$2K – 5538
2017
Q4 		$2K Buy
+1
New +$6.29K ﹤0.01% 4916
2014
Q3 		– Hold
0
– – – 6025
2014
Q2 		– Hold
0
– – – 6002
2014
Q1 		– Hold
0
– – – 5732
2013
Q4 		– Hold
0
– – – 5608
2013
Q3 		– Hold
0
– -$15K – 5681
2013
Q2 		– Hold
0
– – – 4831

Other funds holding OGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank's OGEN Position: Q1 2020 in Review

Deutsche Bank sold out of Oragenics (OGEN) in Q1 2020, closing a stake of 20 shares — an estimated $18K sold.

Deutsche Bank first reported a position in OGEN in Q4 2017 and held it in 4 quarters. The position peaked at $18K in Q4 2019. 12 funds tracked by Wall St. Rank hold OGEN as of Q1 2020.

  • Deutsche Bank reported no remaining Oragenics position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 20 Oragenics shares in Q1 2020, an estimated $18K.
  • Deutsche Bank first reported a position in Oragenics in Q4 2017 and held it in 4 quarters.
  • Deutsche Bank's Oragenics position peaked at $18K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Oragenics as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.